Why the study?
Identifying effective biomarkers for idiopathic inflammatory myopathies has been challenging due to clinical heterogeneity between and within subgroups.
Machine learning algorithms offer a promising approach to overcome the heterogeneity of idiopathic inflammatory myopathies and discover novel diagnostic biomarkers.
May aid IIM biomarker discovery amid heterogeneity; hypothesis-generating and requires prospective validation.
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of muscle disorders including adult and juvenile dermatomyositis, polymyositis, immune-mediated necrotising myopathy and sporadic inclusion body myositis, all of which present with variable symptoms and disease progression. The identification of effective biomarkers for IIMs has been challenging due to the heterogeneity between IIMs and within IIM subgroups, but recent advances in machine learning (ML) techniques have shown promises in identifying novel biomarkers. This paper reviews recent studies on potential biomarkers for IIM and evaluates their clinical utility. We also explore how data analytic tools and ML algorithms have been used to identify biomarkers, highlighting their potential to advance our understanding and diagnosis of IIM and improve patient outcomes. Overall, ML techniques have great potential to revolutionize biomarker discovery in IIMs and lead to more effective diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
McLeish et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: